Navigation Links
UT Southwestern scientist receives NIH Director's New Innovator Award
Date:10/1/2007

DALLAS Oct. 1, 2007 Dr. Tawanda Gumbo, an assistant professor of infectious diseases at UT Southwestern Medical Center, has been named one of the inaugural winners of the National Institutes of Health Directors New Innovator Award.

Dr. Gumbo is one of three Texas scientists and one of 29 nationwide to be named recipients of the award, which provides $1.5 million each over five years and is designed to recognize bold ideas from some of the nations most innovative new scientists. More than 2,100 applications were submitted.

The New Innovator Awards are given to early-career researchers who havent yet received a research project grant from the NIH. The awards are part of the NIH Roadmap for Medical Research, which promotes interdisciplinary and innovative research.

Dr. Gumbos research focuses on tuberculosis and extensively drug-resistant tuberculosis, a newly identified strain of TB that leaves patients virtually untreatable using existing anti-TB drugs. He has published numerous scientific papers on TB, AIDS and other infectious diseases.

About one-third of the worlds population is infected with mycobacterium tuberculosis, the bacterium that causes TB, and as many as 2 million people die of the disease each year. TB, which is the leading cause of death among people infected with HIV/AIDS, kills more people than any other disease caused by a single infectious agent, according to NIH data.

Dr. Beth Levine, professor of internal medicine and microbiology and chief of the division of infectious diseases at UT Southwestern, called the award a great honor for Dr. Gumbo.

The problem of drug resistance is emerging worldwide, Dr. Levine said. The idea that there might be a way to add a drug to prevent the resistance as well as to shorten and simplify therapy for all TB strains has major global health implications for treating this disease.

In his laboratory, Dr. Gumbo measures how antimicrobial drugs behave and how microbes react to those drug concentrations. The aim is to use such information from pharmacokinetics and pharmacodynamics to kill mycobacterium tuberculosis and keep more strains of TB from developing.

Dr. Gumbo said he was thrilled to receive the award.

It will allow me to actually do particular experiments that started with some techniques that I pioneered in the lab using the hollow fiber model of tuberculosis, the native of Zimbabwe said. The typical tuberculosis treatment takes many, many months; usually six months and nine months in some situations. Hopefully, well reduce it to weeks.

Over the five years of the award, Dr. Gumbo will develop a treatment regimen based on blocking the mechanisms that tuberculosis bacteria use to avoid being killed by antibiotics.

Dr. Gumbo, who joined the UT Southwestern faculty in 2006, graduated from the University of Zimbabwe Medical School in Harare, and completed his residency in internal medicine at Case Western Reserve University. He then completed a three-year fellowship to study infectious diseases at the Cleveland Clinic Foundation.

He spent a year doing research at the University of Zimbabwe before accepting a position in 2000 at Albany Medical College and the Ordway Research Institute in Albany, N.Y.

The other winners from Texas were Dr. Pedro Fernandez-Funez of the UT Medical Branch at Galveston and Dr. Kjersti Aagaard-Tillery of Baylor College of Medicine in Houston.


'/>"/>

Contact: Kristen Holland Shear
kristen.hollandshear@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

Related medicine news :

1. Nobel Prize for Medicine shared by Three scientists
2. Scientists plan human cloning clinic in the United States
3. Scientists crack mechanism of Leptin-Obesity Hormone
4. Scientists use plant hormones to fight cancer
5. American scientists alter gene makeup of babies
6. Expose on eating disorders!! Scientists trace “brain’s eating control center pathway”
7. Scientists found ancient Human Germ Killer
8. Scientists locate key hormone involved in appetite control
9. Scientists open the book of life
10. Electronic nose by Italian scientists
11. Scientists review SARS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of ... ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership in ... It also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... ... 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at ... towards children of all ages; it is a non-competitive, non-timed event, which is all ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards luncheon ... editorial and design excellence across a range of sectors. This year’s program included the ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
(Date:9/12/2017)... FRANCISCO , Sept. 12, 2017  ValGenesis ... Management Solutions (VLMS), is pleased to announce the ... a member of its Board of Directors and ... ValGenesis VLMS enables life science companies to manage ... the use of paper in this process. Furthermore, ...
Breaking Medicine Technology: